Form 8-K - Current report:
SEC Accession No. 0001564590-20-003494
Filing Date
2020-02-05
Accepted
2020-02-05 17:13:17
Documents
21
Period of Report
2020-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-8k_20200204.htm   iXBRL 8-K 52968
2 EX-99.1 nbix-ex991_17.htm EX-99.1 405516
3 GRAPHIC gkqtdup4fqpe000001.jpg GRAPHIC 5963
4 GRAPHIC gkqtdup4fqpe000024.jpg GRAPHIC 811
5 GRAPHIC gkqtdup4fqpe000002.jpg GRAPHIC 1436
6 GRAPHIC gkqtdup4fqpe000019.jpg GRAPHIC 811
7 GRAPHIC gkqtdup4fqpe000003.jpg GRAPHIC 3401
8 GRAPHIC gkqtdup4fqpe000027.jpg GRAPHIC 811
9 GRAPHIC gkqtdup4fqpe000011.jpg GRAPHIC 811
10 GRAPHIC gkqtdup4fqpe000016.jpg GRAPHIC 811
  Complete submission text file 0001564590-20-003494.txt   666571

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA nbix-20200204.xsd EX-101.SCH 5976
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20200204_lab.xml EX-101.LAB 18732
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20200204_pre.xml EX-101.PRE 11179
14 EXTRACTED XBRL INSTANCE DOCUMENT nbix-8k_20200204_htm.xml XML 3416
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 20579718
SIC: 2836 Biological Products, (No Diagnostic Substances)